Barry D. Quart
Overview
Barry D. Quart received an average of $5M in total compensation, including $600K in salary, at Heron Therapeutics from 2013 to 2022.
2022Heron TherapeuticsFormer Chief Executive Officer
2021Heron TherapeuticsChief Executive Officer
2020Heron TherapeuticsChief Executive Officer
2019Heron TherapeuticsPresident and Chief Executive Officer
2018Heron TherapeuticsPresident and Chief Executive Officer
2017Heron TherapeuticsPresident and Chief Executive Officer
2015Heron TherapeuticsChief Executive Officer
2014Heron TherapeuticsChief Executive Officer
2013Heron TherapeuticsChief Executive Officer
Related executives
We found 19 more executives who work or worked at Heron Therapeutics.
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
Robert Rosen
Heron Therapeutics
Former President
Neil Clendeninn
Heron Therapeutics
Chief Medical Officer
Paul Marshall
Heron Therapeutics
Senior Vice President, Technical Operations
News
Heron Therapeutics Executive Vice President, Drug Development Kimberly Manhard's 2022 pay falls 22% to $1.4M
May 1, 2023
Heron Therapeutics CEO Barry Quart's 2021 pay rises 2% to $5.4M
April 25, 2022
Heron Therapeutics CEO Barry Quart's 2020 pay slips 9% to $5.3M
April 22, 2021
Heron Therapeutics CEO Barry Quart's 2019 pay slips 2% to $5.9M
April 23, 2020